These data suggested that IL‐33 could attenuate the LPS‐induced endotoxemia and liver injury caused by hepatic PANX1 deficiency by increasing the numbers of liver‐infiltrating ST2+ Tregs and alleviating the early cytokine storm. Here, IL33 is linked to serum lipopolysaccharide activity.